Seckler R, Wright J K
Eur J Biochem. 1984 Jul 16;142(2):269-79. doi: 10.1111/j.1432-1033.1984.tb08281.x.
The orientation of the lactose:H+ carrier of Escherichia coli in various preparations of native and reconstituted vesicles is determined with two impermeant, macromolecular probes: antibodies directed against the C-terminal decapeptide of the carrier and carboxypeptidase A (EC 3.4.17.1). Two methods are employed. Method I is based upon the digestion of all accessible and, therefore, presumably external, C termini of the carrier with carboxypeptidase A and detection of the remaining, internal C termini with 125I-labelled anti-(C-terminus) antibody after electrophoresis of the carrier in the presence of sodium dodecyl sulfate and transfer to nitrocellulose filters. Method II is based upon the binding of 125I-labelled anti-(C-terminus) antibody to the external C termini of the carrier in vesicles and the subsequent isolation of bound antibody by centrifugation. The labelled antibodies are calibrated using a preparation of inside-out vesicles prepared by high-pressure lysis of strain T206. The carrier content is determined by substrate binding. Because the C terminus of the carrier is known to reside on the cytoplasmic side of the membrane, these methods can also be used to determine the sidedness of various preparations of membrane vesicles. Spheroplasts are confirmed to contain carrier molecules of a single orientation, corresponding to that in right-side-out vesicles. In contrast, in purified cytoplasmic membrane vesicles and in crude membrane preparations obtained by sonication or by high-pressure lysis, 96% of the C termini are accessible to carboxypeptidase A, even after repeated sonication. This implies that nearly all carrier molecules in these preparations possess an orientation opposite to that in the cell or in right-side-out vesicles. In proteoliposomes containing carrier reconstituted or purified and reconstituted by two different methods, only 48% of the carrier molecules are oriented in the same way as in the cell. Subjecting such proteoliposomes to cycles of freezing and thawing or to sonication results in a reshuffling of carrier molecules between the inside-out and right-side-out populations while maintaining 41% in the right-side-out orientation. Digestion of the C terminus of the carrier with carboxypeptidase A does not alter either galactoside binding or countertransport. Thus carrier molecules of the inside-out orientation cannot be selectively inactivated. Additionally, an antiserum directed against the purified carrier is demonstrated to contain nearly exclusively anti-(C-terminus) antibodies, which can, in principle, be used in Method I.(ABSTRACT TRUNCATED AT 400 WORDS)
利用两种不能透过膜的大分子探针,即针对乳糖:H⁺载体C端十肽的抗体和羧肽酶A(EC 3.4.17.1),来确定大肠杆菌乳糖:H⁺载体在天然和重组囊泡的各种制剂中的取向。采用了两种方法。方法I基于用羧肽酶A消化载体所有可及的、因此推测为外部的C端,并在十二烷基硫酸钠存在下对载体进行电泳并转移至硝酸纤维素滤膜后,用¹²⁵I标记的抗(C端)抗体检测剩余的内部C端。方法II基于¹²⁵I标记的抗(C端)抗体与囊泡中载体的外部C端结合,随后通过离心分离结合的抗体。使用通过高压裂解菌株T206制备的内翻囊泡制剂对标记抗体进行校准。通过底物结合来确定载体含量。由于已知载体的C端位于膜的细胞质一侧,这些方法也可用于确定各种膜囊泡制剂的内外侧性。证实原生质球含有单一取向的载体分子,与外翻囊泡中的取向一致。相比之下,在纯化的细胞质膜囊泡以及通过超声处理或高压裂解获得的粗膜制剂中,即使经过反复超声处理,96%的C端对羧肽酶A是可及的。这意味着这些制剂中几乎所有的载体分子都具有与细胞或外翻囊泡中相反的取向。在通过两种不同方法重组或纯化并重组的含有载体的蛋白脂质体中,只有48%的载体分子与细胞中的取向相同。对这种蛋白脂质体进行冻融循环或超声处理会导致载体分子在内翻和外翻群体之间重新排列,同时保持41%的外翻取向。用羧肽酶A消化载体的C端不会改变半乳糖苷结合或反向转运。因此,内翻取向的载体分子不能被选择性灭活。此外,针对纯化载体产生的抗血清被证明几乎只含有抗(C端)抗体,原则上可用于方法I。(摘要截短于400字)